期刊文献+

P-糖蛋白与CD44在肿瘤中表达的相关性 被引量:1

Correlation between P- glycoprotein and CD44 in cancer
原文传递
导出
摘要 P-糖蛋白(P—gp)是最重要的肿瘤多药耐药蛋白之一;CD44分子异常表达与肿瘤的侵袭和转移密切相关。近年来的研究发现,P-gp和CD44分子在肿瘤中的表达具有某种相关性,即肿瘤多药耐药与侵袭转移之间可能存在着某种关联。探讨两者可能存在的相关性及深入了解两者之间的内在联系,对肿瘤治疗具有重要的指导意义。 P-glycoprotein (P-gp) and CD44 have been characterized and are known to be determinants of muhidrug resistance (MDR) and cancer metastases. Recent researches suggest that there is a correlation belween P-glycoprotein (MDR) and CD44 (invasion and metastases). A better understanding of any relationship between drug resistance and tumor metastasis may lead to more effective tumor treatment.
出处 《国际肿瘤学杂志》 CAS 2008年第7期489-490,493,共3页 Journal of International Oncology
关键词 P糖蛋白 抗原类 CD44 耐药性 肿瘤 肿瘤侵袭 肿瘤转移 P- glycoprotein Antigens, CD44 Drug resistance, neoplasm Neoplasm invasiveness Neoplasm metastasis
  • 相关文献

参考文献3

二级参考文献11

共引文献67

同被引文献19

  • 1Pimia F, Breuleux M, Schneider E,et al. Uncertain identity of doxoru-bicin-resistant MCF-7 cell lines expressing mutated p53 [J]. J NatlCancer Inst, 2000, 92(18):1535-1536.
  • 2Mehta K, Devarajan E, Chen J, et al. Multidrug-resistant MCF-7 cells:an identity crisis.[J]. J Natl Cancer Inst, 2002, 94(21):1652-1654.
  • 3Liscovitch M, Ravid D. A case study in misidentification of cancer celllines: MCF-7/AdrR cells (re-designated NC1/ADR-RES) are derivedfrom OVCAR-8 human ovarian carcinoma cells [J]. Cancer Lett,2007,245(1-2):350-352.
  • 4Ke W, Yu P, Wang J, et al. MCF-7/ADR cells (re-designatedNCI/ADR-RES) are not derived from MCF-7 breast cancer cells: aloss for breast cancer multidrug-resistant research [J]. Med Oncol,20Il,28suppll:S135-141.
  • 5Yu P, Zhou L,Ke W, et al. Clinical significance of pAKT andCD44v6 overexpression with breast cancer [J]. J Cancer Res Clin Oncol,2010,136(8):1283-1292.
  • 6Ambudkar SV, Kimchi-Sarfaty C, Sauna Z, et al. P-glycoprotein:from genomics to mechanism[J]. Oncogene, 2003,22(47):7468-7485.
  • 7Sauna Z E, Kim I W, Ambudkar S V. Genomics and the mechanismof P-glycoprotein (ABCB1)[J]. J Bioenerg Biomembr, 2007, 39(5-6):481-487.
  • 8Tsuruo T, Naito M, Tomida A, et al. Molecular targeting therapy ofcancer: drug resistance, apoptosis and survival signal [J]. Cancer Sci,2003,94(1):15-21.
  • 9Bjomland K, Lehne G, Johansen H T, et al. Human hepatoma cellsrich in P-glycoprotein display enhanced in vitro invasive propertiescompared to P-glycoprotein-poor hepatoma cells[J]. Oncol Res, 1998,10(5):255-262.
  • 10Barancik M, Bohacova V,Sedlak J, et al. LY294002, a specific inhi-bitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-medi-ated multidrug resistance卩].Eur J Pharm Sci, 2006, 29(5):426-434.

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部